GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biomarin Pharmaceutical Inc. (BMRN) [hlAlert]

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The
company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
( Total: 35 Current Stock Recommendations )
Biomarin Pharmaceutical Inc.   (35)
Hold 37% Buy 63%
Related companies
Forest ...   (37)
Sell Hold 51% Buy 43%
Perrigo Company   (24)
Hold 29% Buy 71%
Valeant ...   (27)
Sell 15% Hold 26% Buy 59%
Vertex ...   (44)
Sell Hold 36% Buy 59%
Allergan Plc   (28)
Hold 29% Buy 71%
Biogen Idec Inc   (41)
Sell Hold 27% Buy 68%
Mylan Laboratories, ...   (21)
Hold 29% Buy 71%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
9/18/2013  
Hold
  
11/6/2012  
Hold
  
5/7/2013  
Buy
  
8/7/2012  
Buy
  
2/19/2014  
Buy
  
9/28/2012  
Buy
  
6/18/2015  
Buy
  
10/5/2015  
Hold
  
6/18/2015  
Buy
  
3/12/2009  
Buy
  
2/19/2009  
Hold
  
2/19/2009  
Hold
  
4/29/2011  
Buy
  
3/31/2009  
Hold
  
9/13/2010  
Hold
  
3/12/2009  
Buy
  
8/22/2008  
Buy
  
9/12/2008  
Buy
  
7/31/2009  
Hold
  
12/23/2008  
Hold
  
11/2/2007  
Buy
  
2/19/2009  
Hold
  
10/24/2014  
Buy
  
11/25/2015  
None
  
5/27/2015  
Buy
  
3/4/2009  
Buy
  
12/11/2014  
Buy
  
1/22/2013  
Buy
  
8/6/2008  
Buy
  
2/9/2010  
Buy
  
6/19/2015  
Hold
  
11/27/2013  
Buy
  
11/1/2010  
Hold
  
10/8/2009  
Buy
  
5/31/2013  
Hold
  
3/19/2012  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy